-
公开(公告)号：US10993961B2
公开(公告)日：2021-05-04
申请号：US13805040
申请日：2011-06-20
IPC分类号： A61K33/14 , A61K33/00 , A61K9/00 , A61K31/7004 , A61K33/06 , A61M1/28 , A61K31/19 , A61K31/191 , A61K31/366 , A61K31/385 , A61K31/194 , A61K31/198
摘要： The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consist of powder components comprising sodium chloride, at least one dry acid and at least one magnesium salt, and optionally potassium salt, calcium salt, and glucose. According to the invention said at least one magnesium salt and said optional glucose, are present as anhydrous components in said dialysis acid precursor composition.
-
公开(公告)号：US20130183389A1
公开(公告)日：2013-07-18
申请号：US13805040
申请日：2011-06-20
IPC分类号： A61K33/14
CPC分类号： A61K33/14 , A61K9/0029 , A61K9/0095 , A61K31/19 , A61K31/191 , A61K31/194 , A61K31/198 , A61K31/366 , A61K31/385 , A61K31/7004 , A61K33/00 , A61K33/06 , A61M1/287 , A61K2300/00
摘要： The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consist of powder components comprising sodium chloride, at least one dry acid and at least one magnesium salt, and optionally potassium salt, calcium salt, and glucose. According to the invention said at least one magnesium salt and said optional glucose, are present as anhydrous components in said dialysis acid precursor composition.
摘要翻译： 本发明涉及一种透析酸前体组合物，用于制备透析酸浓缩液，并与水和含碳酸氢盐的浓缩液混合成即用型透析溶液。 所述透析酸前体组合物由包含氯化钠，至少一种干酸和至少一种镁盐，以及任选的钾盐，钙盐和葡萄糖的粉末组分组成。 根据本发明，所述至少一种镁盐和所述任选的葡萄糖以所述透析酸前体组合物中的无水组分存在。
-
公开(公告)号：US20130189376A1
公开(公告)日：2013-07-25
申请号：US13805474
申请日：2011-06-20
IPC分类号： A61K33/14 , A61K31/19 , A61K31/7004 , A61K31/191 , A61K31/194
CPC分类号： A61K33/14 , A61K9/0029 , A61K9/0095 , A61K31/185 , A61K31/19 , A61K31/191 , A61K31/194 , A61K31/7004 , A61K33/00 , A61K33/06 , A61K33/10 , A61M1/1666 , A61M1/287 , A61K2300/00
摘要： The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water, a sodium containing concentrate, and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consists of powder components comprising glucose, at least one dry acid and at least one magnesium salt, and optionally potassium salt, and calcium salt. According to the invention said glucose and said at least one magnesium salt, are present as anhydrous components in said dialysis acid precursor composition.
摘要翻译： 本发明涉及一种透析酸前体组合物，用于制备透析酸浓缩液，并与水，含钠浓缩物和含碳酸氢盐的浓缩液混合成即用型透析溶液。 所述透析酸前体组合物由包含葡萄糖，至少一种干酸和至少一种镁盐，以及任选的钾盐和钙盐的粉末组分组成。 根据本发明，所述葡萄糖和所述至少一种镁盐以所述透析酸前体组合物中的无水组分存在。
-
公开(公告)号：US09138380B2
公开(公告)日：2015-09-22
申请号：US13805557
申请日：2011-06-20
申请人： Olof Jansson , Lennart Jonsson , Torbjorn Linden , Jan Sternby , Ragnar Tryggvason , Anders Wieslander
发明人： Olof Jansson , Lennart Jonsson , Torbjorn Linden , Jan Sternby , Ragnar Tryggvason , Anders Wieslander
CPC分类号： A61J1/20 , A61J1/2093 , A61M1/1656 , A61M1/1666 , A61M1/1668 , A61M1/167 , A61M1/287 , B65D31/14 , B65D81/18 , B65D81/20 , B65D81/2007 , B65D81/2023 , B65D81/2046
摘要： A package has a transport/storage state for storing powdery material which is to be mixed with a solvent to form a medical solution. The package includes a compartment which is at least partially defined by two opposing wall portions, and a connector. In the transport/storage state, the compartment contains the powdery material in the form of at least two distinct sets of powdery material of different compositions, where the opposing wall portions are brought into engagement with the powdery material so as to immobilize the sets of powdery material. When used for preparation of the medical solution, a fluid is selectively admitted into the package via the connector so as to expand the compartment and enable mixing of the sets of powdery material with the solvent in the compartment.
摘要翻译： 包装具有用于储存待与溶剂混合以形成医用溶液的粉末状材料的运输/储存状态。 该包装包括至少部分地由两个相对的壁部分限定的隔室和连接器。 在运输/储存状态下，隔室含有至少两组不同组成的粉末状材料形式的粉状材料，其中相对的壁部分与粉末材料接合，从而固定该组粉末状 材料。 当用于制备医用溶液时，通过连接器将流体选择性地进入包装中，以便使隔室膨胀并且使得能够将该组粉末材料与隔室中的溶剂混合。
-
公开(公告)号：US20130190681A1
公开(公告)日：2013-07-25
申请号：US13805557
申请日：2011-06-20
申请人： Olof Jansson , Lennart Jonsson , Torbjorn Linden , Jan Sternby , Ragnar Tryggvason , Anders Wieslander
发明人： Olof Jansson , Lennart Jonsson , Torbjorn Linden , Jan Sternby , Ragnar Tryggvason , Anders Wieslander
CPC分类号： A61J1/20 , A61J1/2093 , A61M1/1656 , A61M1/1666 , A61M1/1668 , A61M1/167 , A61M1/287 , B65D31/14 , B65D81/18 , B65D81/20 , B65D81/2007 , B65D81/2023 , B65D81/2046
摘要： A package has a transport/storage state for storing powdery material which is to be mixed with a solvent to form a medical solution. The package includes a compartment which is at least partially defined by two opposing wall portions, and a connector. In the transport/storage state, the compartment contains the powdery material in the form of at least two distinct sets of powdery material of different compositions, where the opposing wall portions are brought into engagement with the powdery material so as to immobilize the sets of powdery material. When used for preparation of the medical solution, a fluid is selectively admitted into the package via the connector so as to expand the compartment and enable mixing of the sets of powdery material with the solvent in the compartment.
摘要翻译： 包装具有用于储存待与溶剂混合以形成医用溶液的粉末状材料的运输/储存状态。 该包装包括至少部分地由两个相对的壁部分限定的隔室和连接器。 在运输/储存状态下，隔室含有至少两组不同组成的粉末状材料形式的粉状材料，其中相对的壁部分与粉末材料接合，从而固定该组粉末状 材料。 当用于制备医用溶液时，通过连接器将流体选择性地进入包装中，以便使隔室膨胀并且使得能够将该组粉末材料与隔室中的溶剂混合。
-
6.发明申请Connecting device, a medical system, and a method of connecting medical subsystems 有权连接装置，医疗系统以及连接医疗子系统的方法公开(公告)号：US20070073215A1
公开(公告)日：2007-03-29
申请号：US10568219
申请日：2004-08-16
申请人： Anders Wieslander , Sten-Borje Lindqvist , Ellinor Broms , Eddie Nilsson , Per Kjellstrand , Lennart Jonsson , Ola Carlsson
发明人： Anders Wieslander , Sten-Borje Lindqvist , Ellinor Broms , Eddie Nilsson , Per Kjellstrand , Lennart Jonsson , Ola Carlsson
IPC分类号： A61M1/00
摘要： The invention refers to a medical system comprising a first subsystem with a first connection portion (7), and a second subsystem with a second connection portion (12). The invention also refers to a device and a method for connecting the subsystems to each other. One of the subsystems contains a fluid. The connecting device is adapted to connect the subsystems to each other to permit transport of the fluid from one of the subsystems to the other subsystem. The device comprises a container (21) enclosing an inner space. A substantially sterile atmosphere is provided in the inner space. The container receives the first connection portion and the second connection portion in the inner space. A mechanism is provided for connecting, from outside the container, the first connection portion and the second connection portion to each other in the inner space.
摘要翻译： 本发明涉及包括具有第一连接部分（7）的第一子系统和具有第二连接部分（12）的第二子系统的医疗系统。 本发明还涉及用于将子系统彼此连接的装置和方法。 其中一个子系统包含流体。 连接装置适于将子系统彼此连接以允许流体从一个子系统传输到另一个子系统。 该装置包括封闭内部空间的容器（21）。 在内部空间设置基本无菌的气氛。 容器容纳内部空间中的第一连接部分和第二连接部分。 提供了一种机构，用于在内部空间中将第一连接部分和第二连接部分从容器的外部连接到彼此。
-
公开(公告)号：US09999715B2
公开(公告)日：2018-06-19
申请号：US14122474
申请日：2012-05-23
CPC分类号： A61M1/14 , A61M1/168 , A61M1/1682 , A61M1/1684 , A61M1/169 , A61M1/3643 , A61M1/3644 , A61M1/3649
摘要： A blood treatment apparatus adapted to preserve a blood treatment unit between blood treatment sessions. The blood treatment apparatus is configured to i) perform a blood treatment session and thereby use the blood treatment unit, ii) fill the blood treatment unit with a preservation fluid comprising at least one treatment fluid concentrate of a type that is used to prepare the treatment fluid, iii) maintain the preservation fluid in the blood treatment unit until a next blood treatment session is prepared, iv) dispatch the preservation fluid from the blood treatment unit in preparation of a next blood treatment session, and v) perform a next blood treatment session and thereby extend the use of the blood treatment unit. A related method is also described.
-
8.发明申请AMBULATORY ULTRAFILTRATION DEVICE, RELATED METHODS AND A COMPUTER PROGRAM PRODUCT 有权强制超声波装置，相关方法和计算机程序产品公开(公告)号：US20130228516A1
公开(公告)日：2013-09-05
申请号：US13808770
申请日：2011-06-16
申请人： Lennart Jonsson , Jan Sternby , Anders Wieslander
发明人： Lennart Jonsson , Jan Sternby , Anders Wieslander
IPC分类号： A61M1/30
CPC分类号： A61M1/30 , A61M1/302 , A61M1/303 , A61M1/3427 , A61M1/3604 , A61M1/365 , A61M1/3672 , A61M2209/088
摘要： An ambulatory ultrafiltration device includes a blood filter that has a blood side or fluid communication with the vascular system of the subject, an ultrafiltrate side, and a semipermeable membrane disposed between the blood side and the ultrafiltrate side. The ambulatory ultrafiltration also includes a buffer vessel in fluid communication with the blood side of the blood filter, and a blood pump. The blood pump is controlled to alternate between a withdrawal phase and a return phase. In the withdrawal phase, blood is withdrawn on a blood path from the subject via the blood filter to the buffer vessel. In the return phase, blood is returned from the buffer vessel to the subject on the blood path. The blood filter is arranged to remove ultrafiltrate from the blood during at least one of the withdrawal and return phases.
摘要翻译： 动态超滤装置包括具有与受试者的血管系统血液侧或流体连通的血液过滤器，超滤液侧和设置在血液侧和超滤液侧之间的半透膜。 动态超滤还包括与血液过滤器的血液侧流体连通的缓冲容器和血液泵。 血泵被控制在戒断阶段和返回阶段之间交替。 在抽出阶段，血液在血液路径上从被检体经由血液过滤器抽出到缓冲容器。 在返回阶段，血液从血液通道从缓冲容器返回到受检者。 血液过滤器布置成在至少一个撤出和返回阶段期间从血液中除去超滤液。
-
公开(公告)号：US09636445B2
公开(公告)日：2017-05-02
申请号：US13808770
申请日：2011-06-16
申请人： Lennart Jonsson , Jan Sternby , Anders Wieslander
发明人： Lennart Jonsson , Jan Sternby , Anders Wieslander
CPC分类号： A61M1/30 , A61M1/302 , A61M1/303 , A61M1/3427 , A61M1/3604 , A61M1/365 , A61M1/3672 , A61M2209/088
摘要： An ambulatory ultrafiltration device includes a blood filter that has a blood side or fluid communication with the vascular system of the subject, an ultrafiltrate side, and a semipermeable membrane disposed between the blood side and the ultrafiltrate side. The ambulatory ultrafiltration also includes a buffer vessel in fluid communication with the blood side of the blood filter, and a blood pump. The blood pump is controlled to alternate between a withdrawal phase and a return phase. In the withdrawal phase, blood is withdrawn on a blood path from the subject via the blood filter to the buffer vessel. In the return phase, blood is returned from the buffer vessel to the subject on the blood path. The blood filter is arranged to remove ultrafiltrate from the blood during at least one of the withdrawal and return phases.
-
公开(公告)号：US20140248600A1
公开(公告)日：2014-09-04
申请号：US14122474
申请日：2012-05-23
IPC分类号： A61M1/14
CPC分类号： A61M1/14 , A61M1/168 , A61M1/1682 , A61M1/1684 , A61M1/169 , A61M1/3643 , A61M1/3644 , A61M1/3649
摘要： A blood treatment apparatus adapted to preserve a blood treatment unit between blood treatment sessions. The blood treatment apparatus is configured to i) perform a blood treatment session and thereby use the blood treatment unit, ii) fill the blood treatment unit with a preservation fluid comprising at least one treatment fluid concentrate of a type that is used to prepare the treatment fluid, iii) maintain the preservation fluid in the blood treatment unit until a next blood treatment session is prepared, iv) dispatch the preservation fluid from the blood treatment unit in preparation of a next blood treatment session, and v) perform a next blood treatment session and thereby extend the use of the blood treatment unit. A related method is also described.
摘要翻译： 一种血液处理装置，适于在血液处理会话之间保留血液处理单元。 血液处理装置被构造成：i）进行血液处理会话，从而使用血液处理单元，ii）用包含至少一种用于制备治疗类型的处理流体浓缩物的保存液填充血液处理单元 流体，iii）保持血液处理单元中的保存液体，直到准备下一个血液处理会话，iv）在准备下一个血液治疗期间从血液处理单元分派保存液，以及v）进行下一个血液处理 从而延长了血液处理单元的使用。 还描述了相关方法。
-
-
-
-
-
-
-
-
-
搜索结果
44 条记录 (耗时 0.025 秒)
